{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:42:37Z","timestamp":1790710957729,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of the Report<\/jats:title>\n                    <jats:p>Prostate-specific membrane antigen (PSMA) is a member of superfamily of zinc-dependent exopeptidases that is robustly expressed in prostate cancer cells and nonprostatic solid tumor neovasculature including microvessels of thyroid tumors. Its expression in differentiated thyroid cancer (DTC) has been confirmed in many recent studies, but systematic studies exploring PSMA expression in patients with DTC with thyroglobulin elevation and negative iodine scintigraphy (TENIS) are lacking. The aim of the present study was to evaluate the role of PSMA scan in TENIS patients with DTC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Nine consecutive patients with DTC with proven TENIS syndrome (6 men and 3 women with age range 29\u201368 years and mean age of 48 years) underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT as per the institution protocol. Thereafter, they were subjected to\n                      <jats:sup>68<\/jats:sup>\n                      Ga-PSMA-HBED-CC PET\/CT as per the institution protocol within a week of FDG PET imaging. Prostate-specific membrane antigen expression (SUVmax) in the lesions was compared with\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET and CT scan findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 5 of 9 patients with TENIS, the metastatic lesions showed PSMA expression. A total of 14 lesions were seen on the CT scan. Prostate-specific membrane antigen PET detected 9 of 14 lesions (64.28%) (SUVmax ranging from 10.1 to 45.67; median SUVmax of 16.31), whereas FDG PET was positive in 11 of 14 lesions (78.57%). The lesions that showed PSMA uptake was localized to bones (5 of 9) and lungs (4 of 9). Two lesions that were localized to iliac crest and acetabulum were missed on FDG PET but were seen on CT and PSMA PET scan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The results of this pilot study indicate that\n                      <jats:sup>68<\/jats:sup>\n                      Ga-HBED-CC-PSMA PET\/CT demonstrates PSMA expression in TENIS patients with lesions being localized to the bones and lungs.\n                      <jats:sup>68<\/jats:sup>\n                      Ga-PSMA PET\/CT could be useful for the identification of TENIS patients who might benefit from PSMA-targeted radionuclide therapy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003655","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T11:58:34Z","timestamp":1619092714000},"page":"e406-e409","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET\/CT"],"prefix":"10.1097","volume":"46","author":[{"given":"Priyanka","family":"Verma","sequence":"first","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilas","family":"Meshram","sequence":"additional","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Chandak","sequence":"additional","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Sonavane","sequence":"additional","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag R.","family":"Lila","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar R.","family":"Bandgar","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh V.","family":"Asopa","sequence":"additional","affiliation":[{"name":"Radiation Medicine Centre, Bhabha Atomic Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1038\/s41598-018-22594-1","article-title":"PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis","volume":"8","year":"2018","journal-title":"Sci Rep"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2967\/jnumed.117.191023","article-title":"(177)Lu-PSMA radioligand therapy for prostate cancer","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib3-20250621","first-page":"241","article-title":"Prostate-specific membrane antigen as a target for cancer imaging and therapy","volume":"59","year":"2015","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/ijnm.IJNM_65_18","article-title":"A review of TENIS syndrome in hospital Pulau Pinang","volume":"33","year":"2018","journal-title":"Indian J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3413\/nukmed-0302","article-title":"Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial","volume":"49","year":"2010","journal-title":"Nuklearmedizin"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1758834014548188","article-title":"Treatment strategies for radioactive iodine\u2013refractory differentiated thyroid cancer","volume":"6","year":"2014","journal-title":"Ther Adv Med Oncol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/RLU.0000000000002161","article-title":"Evidence of prostate-specific membrane antigen expression in metastatic differentiated thyroid cancer using 68Ga-PSMA-HBED-CC PET\/CT","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13550-020-00720-3","article-title":"Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study","volume":"10","year":"2020","journal-title":"EJNMMI Res"},{"key":"bib9-20250621","first-page":"5202","article-title":"PSMA expression by microvasculature of thyroid tumors\u2014potential implications for PSMA theranostics","volume":"12","year":"2017","journal-title":"Sci Rep"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/RLU.0000000000001454","article-title":"Imaging of prostate-specific membrane antigen expression in metastatic differentiated thyroid cancer using 68Ga-HBED-CC-PSMA PET\/ CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/RLU.0000000000001992","article-title":"Rare case of intratracheal metastasis detected on 68Ga\u2013prostate-specific membrane antigen PET\/CT scan in a case of thyroglobulin elevated negative iodine scan syndrome","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/thy.2013.0225","article-title":"Differentiated thyroid cancer: a new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients","volume":"24","year":"2014","journal-title":"Thyroid"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/105072501750362718","article-title":"Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer","volume":"11","year":"2001","journal-title":"Thyroid"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40336-020-00390-0","article-title":"FDG PET\/CT versus somatostatin receptor PET\/CT in TENIS syndrome: a systematic review and meta-analysis","volume":"8","year":"2020","journal-title":"Clin Transl Imaging"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13550-019-0559-9","article-title":"PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome","volume":"9","year":"2019","journal-title":"EJNMMI Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T17:03:23Z","timestamp":1750525403000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003655","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,21]]}}}